🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
3.310
-0.070 (-2.07%)
Nov 18, 2026, 10:50 AM EST - Market open

Aclaris Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
20.3919.9624.5739.8845.2827.35
Short-Term Investments
93.970.7989.0279.23172.29164.07
Cash & Short-Term Investments
114.2990.75113.59119.11217.57191.41
Cash Growth
19.16%-20.11%-4.63%-45.26%13.66%253.61%
Receivables
8.945.5712.360.30.480.62
Prepaid Expenses
---9.4513.513
Total Current Assets
123.2396.32125.95128.86231.55205.03
Property, Plant & Equipment
2.463.053.855.483.784.77
Long-Term Investments
90.3160.6190.362.7712.2434.24
Other Intangible Assets
----6.977.05
Other Long-Term Assets
0.160.490.220.30.050.12
Total Assets
216.16160.46220.33197.41254.6251.21

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
9.0713.164.698.8810.359.99
Accrued Expenses
7.067.417.7610.868.27.37
Current Portion of Leases
0.610.550.480.430.680.72
Current Unearned Revenue
3.973.943.89---
Other Current Liabilities
3.513.5814.7710.792.74.85
Total Current Liabilities
24.2228.6531.630.9521.9422.93
Long-Term Leases
1.11.572.123.071.572.17
Long-Term Unearned Revenue
13.3316.1720.04---
Long-Term Deferred Tax Liabilities
----0.370.37
Other Long-Term Liabilities
10.71111.026.233.128.4
Total Liabilities
49.3657.3864.7740.2356.9853.87

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
000000
Additional Paid-In Capital
1,1961,0701,058928.08880.83792.97
Retained Earnings
-1,028-967.78-902.86-770.8-682.32-595.41
Comprehensive Income & Other
-1.120.610.1-0.11-0.9-0.22
Shareholders' Equity
166.8103.08155.55157.18197.62197.34
Total Liabilities & Equity
216.16160.46220.33197.41254.6251.21

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
1.712.122.63.52.252.89
Net Cash (Debt)
202.9149.25201.3178.38227.56222.76
Net Cash Growth
22.99%-25.86%12.85%-21.61%2.15%457.17%
Net Cash Per Share
1.491.222.602.563.493.93
Filing Date Shares Outstanding
158.61120.6107.9270.9366.6961.28
Total Common Shares Outstanding
150.83120.5107.8570.8966.6961.23
Working Capital
99.0167.6794.3697.9209.61182.1
Book Value Per Share
1.110.861.442.222.963.22
Tangible Book Value
166.8103.08155.55157.18190.65190.29
Tangible Book Value Per Share
1.110.861.442.222.863.11
Machinery
---4.974.013.61
Leasehold Improvements
---0.821.121.12
SEC Filings: 10-K · 10-Q